Robust prediction of anti-cancer drug sensitivity and sensitivity-specific biomarker.
The personal genomics era has attracted a large amount of attention for anti-cancer therapy by patient-specific analysis. Patient-specific analysis enables discovery of individual genomic characteristics for each patient, and thus we can effectively predict individual genetic risk of disease and per...
Main Authors: | Heewon Park, Teppei Shimamura, Satoru Miyano, Seiya Imoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4201473?pdf=render |
Similar Items
-
Xprediction: Explainable EGFR-TKIs response prediction based on drug sensitivity specific gene networks.
by: Heewon Park, et al.
Published: (2022-01-01) -
Recursive Random Lasso (RRLasso) for Identifying Anti-Cancer Drug Targets.
by: Heewon Park, et al.
Published: (2015-01-01) -
PredictiveNetwork: predictive gene network estimation with application to gastric cancer drug response-predictive network analysis
by: Heewon Park, et al.
Published: (2022-08-01) -
Comprehensive information-based differential gene regulatory networks analysis (CIdrgn): Application to gastric cancer and chemotherapy-responsive gene network identification
by: Heewon Park, et al.
Published: (2023-01-01) -
Comprehensive information-based differential gene regulatory networks analysis (CIdrgn): Application to gastric cancer and chemotherapy-responsive gene network identification.
by: Heewon Park, et al.
Published: (2023-01-01)